| NCT Number | NCT06909422 |
| Lead Sponsor | University of Alabama at Birmingham |
| Conditions | Schizophrenia, Clinical High Risk for Psychosis (CHR) |
| Enrollment | 100 participants |
| Start Date | 2026-12 |
| Primary Completion | 2028-08 (estimated) |
| Study Completion | 2028-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-29 |